Although IL-1β is a central pathogenic factor for life-threatening post-operative systemic inflammation that can cause sepsis, therapies targeting the IL-1 system were unsuccessful so far (Bortolotti et al., 2018), most probably because these therapies increase the risk for infectious complications. The gene discussed is IL1B; the disease is Sepsis.